Effect of Apolipoprotein C-I on Gastric Cancer Cell Lines in Vitroand the Biological Characteristics

Zhao Yuzhou,Liu Chenyu,Zhang Junjie,Guo Fei,Zhao Wei,Li Hao,Zhan Yuxiao,Wang Jiaxiang

DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2017.06.024

2017-01-01

Abstract:Objective To investigate the effect of apolipoprotein C-I on the growth inhibition of gastric cancer cell lines.Methods Fluorescent labeled apolipoprotein C-I protein was incubated with HGC-27 and MGC-803 cell suspension, and the uptake of apolipoprotein C-I protein was observed under fluorescence microscope.The five groups were set up with different concentrations of apolipoprotein C-I (0.1, 0.5, 1.0, 1.5, 2.0 μg/μL), and the control group and the blank group were created.At three time points of 24, 48 and 72 h, the cells were incubated with cell counting kit-8 (CCK-8) for 1.5 h, and the absorbance (A) at a wavelength of 450 nm (A450 nm) was measured.Results The results showed that apolipoprotein C-I significantly inhibited the proliferation of HGC27 cells (24 h: 5.29%, 15.11%, 53.40%, 82.12%, 90.43%,P=0.002;48 h: 8.82%, 21.91%, 58.94%, 86.45%, 94.46%, P=0.002;72 h: 11.08%, 29.72%, 68.51%, 87.91%, 95.72%,P=0.003) and MGC803 cells (24 h: 4.03%, 13.35%, 43.32%, 78.84%, 91.44%,P=0.001;48 h: 7.56%, 29.72%, 63.22%, 86.62%, 93.45%,P=0.001;72 h: 9.32%, 35.77%, 74.81%, 86.90%, 98.74%,P=0.004).Conclusion Apolipoprotein C-I has cytotoxic effect on human gastric cancer cells, probably as a new antitumor drug.Apolipoprotein C-I may become a new drug target for treatment of gastric cancer, and may also play an important role in the treatment of other types of tumor.